Skip to main content
. 2008 Nov 6;105(45):17408–17413. doi: 10.1073/pnas.0809013105

Table 1.

Ricin cell-surface to cytosol trafficking times

Treatment T, min
100 μg ml−1 lactose carrier 62.4 ± 1.2
50 μg ml−1 DSG/ lactose 64.7 ± 1.8
0.001% DMSO vehicle 68.0 ± 6.3
1 μM geldanamycin/DMSO 63.4 ± 9.8
1 μM radicicol/DMSO 65.2 ± 8.3

T, n = 3–6, ± 1 SD.

HHS Vulnerability Disclosure